FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897364747> ?p ?o ?g. }

• W2897364747 endingPage "viii591" @default.
• W2897364747 startingPage "viii591" @default.
• W2897364747 abstract "Background: We aimed to describe clinico-pathological features and outcomes of Rahbdomyosarcoma (RMS) in Tunisia. Methods: We assembled a retrospective cohort of 47 patients aged 18 or older diagnosed with, and treated for RMS at our institute between 1994 and 2013. Patient's characteristics, tumor variables and treatment outcomes were evaluated. Tumors were classified according to the Intergroup RMS Study (IRS) staging. Results: Median age was 39 and 66% were male. At presentation, 33 had localised disease and 14 metastatic. Metastasis site was lung in 17% of cases. Sixteen patients had node positive disease. Median tumor size was 9 cm. Patients presented with swelling or palpable mass in 63.8% of cases, pain in 17%, exophthalmia in 6.4% and bleeding in 4.3%. Less common clinical presentations were functional impairment, cranial nerve palsies, superior vena cava syndrome and nasal obstruction seen in one case each. Tumor site was extremities in 40.4% of cases, trunk in 23.4%, head and neck in 19.1% and genito-urinary tract in 17%. According to favorable/unfavorable prognostic location, tumor site was unfavorable in 65.9% of cases and favorable in 33.9%. RMS histologic subtype was pleomorphic in 36.2% of patients, embryonic in 25.5%, not mentioned in 23.4%, alveolar in 12.8% and combination of embryonic and alveolar in 2.1%. Among 38 patients who underwent surgery, 40.4% had complete resection (IRS stage I). Chemotherapy was adjuvant in 4 patients, neoadjuvant in 6 and 1st line in 13 with a median number of cycle of 3 in each schedule. Radiotherapy (RT) was adjuvant in 19.1% of cases and symptomatic/palliative in 21.1%. Median dose of adjuvant RT was 55 Gray. Median progression free survival after adjuvant treatment was 4.5 months, 47.1% relapsed locally, 35.3% developed distant metastasis and 17.6% presented local recurrence with distant metastases. Five year overall survival (OS) was 46% for localised RMS and 40% for metastatic disease. Among all studied factors, non operated patients and those under 30 years old had worse OS with p values of 0.005 and 0 respectively. Conclusions: Adults with RMS have poor prognosis. All patients should therefore undergo multimodality treatment comprising of surgery, radiation, and chemotherapy to achieve better outcomes. Legal entity responsible for the study: Amel Mezlini. Funding: Has not received any funding. Disclosure: All authors have declared no conflicts of interest." @default.
• W2897364747 created "2018-10-26" @default.
• W2897364747 creator A5000972382 @default.
• W2897364747 creator A5008382383 @default.
• W2897364747 creator A5019469385 @default.
• W2897364747 creator A5036270827 @default.
• W2897364747 creator A5039698135 @default.
• W2897364747 creator A5055281182 @default.
• W2897364747 creator A5055400337 @default.
• W2897364747 creator A5057611157 @default.
• W2897364747 creator A5068463772 @default.
• W2897364747 creator A5082524586 @default.
• W2897364747 creator A5086920658 @default.
• W2897364747 date "2018-10-01" @default.
• W2897364747 modified "2023-09-27" @default.
• W2897364747 title "Adult rhabdomyosarcoma in Tunisia: Clinical presentation, treatment and outcome" @default.
• W2897364747 doi "https://doi.org/10.1093/annonc/mdy299.045" @default.
• W2897364747 hasPublicationYear "2018" @default.
• W2897364747 type Work @default.
• W2897364747 sameAs 2897364747 @default.
• W2897364747 citedByCount "0" @default.
• W2897364747 crossrefType "journal-article" @default.
• W2897364747 hasAuthorship W2897364747A5000972382 @default.
• W2897364747 hasAuthorship W2897364747A5008382383 @default.
• W2897364747 hasAuthorship W2897364747A5019469385 @default.
• W2897364747 hasAuthorship W2897364747A5036270827 @default.
• W2897364747 hasAuthorship W2897364747A5039698135 @default.
• W2897364747 hasAuthorship W2897364747A5055281182 @default.
• W2897364747 hasAuthorship W2897364747A5055400337 @default.
• W2897364747 hasAuthorship W2897364747A5057611157 @default.
• W2897364747 hasAuthorship W2897364747A5068463772 @default.
• W2897364747 hasAuthorship W2897364747A5082524586 @default.
• W2897364747 hasAuthorship W2897364747A5086920658 @default.
• W2897364747 hasBestOaLocation W28973647471 @default.
• W2897364747 hasConcept C121608353 @default.
• W2897364747 hasConcept C126322002 @default.
• W2897364747 hasConcept C141071460 @default.
• W2897364747 hasConcept C142724271 @default.
• W2897364747 hasConcept C146357865 @default.
• W2897364747 hasConcept C151730666 @default.
• W2897364747 hasConcept C167135981 @default.
• W2897364747 hasConcept C207886595 @default.
• W2897364747 hasConcept C2778256501 @default.
• W2897364747 hasConcept C2779013556 @default.
• W2897364747 hasConcept C2780283643 @default.
• W2897364747 hasConcept C2780844630 @default.
• W2897364747 hasConcept C71924100 @default.
• W2897364747 hasConcept C86803240 @default.
• W2897364747 hasConceptScore W2897364747C121608353 @default.
• W2897364747 hasConceptScore W2897364747C126322002 @default.
• W2897364747 hasConceptScore W2897364747C141071460 @default.
• W2897364747 hasConceptScore W2897364747C142724271 @default.
• W2897364747 hasConceptScore W2897364747C146357865 @default.
• W2897364747 hasConceptScore W2897364747C151730666 @default.
• W2897364747 hasConceptScore W2897364747C167135981 @default.
• W2897364747 hasConceptScore W2897364747C207886595 @default.
• W2897364747 hasConceptScore W2897364747C2778256501 @default.
• W2897364747 hasConceptScore W2897364747C2779013556 @default.
• W2897364747 hasConceptScore W2897364747C2780283643 @default.
• W2897364747 hasConceptScore W2897364747C2780844630 @default.
• W2897364747 hasConceptScore W2897364747C71924100 @default.
• W2897364747 hasConceptScore W2897364747C86803240 @default.
• W2897364747 hasLocation W28973647471 @default.
• W2897364747 hasOpenAccess W2897364747 @default.
• W2897364747 hasPrimaryLocation W28973647471 @default.
• W2897364747 hasRelatedWork W1960864063 @default.
• W2897364747 hasRelatedWork W2055887390 @default.
• W2897364747 hasRelatedWork W2180480917 @default.
• W2897364747 hasRelatedWork W2357394130 @default.
• W2897364747 hasRelatedWork W2408995019 @default.
• W2897364747 hasRelatedWork W3032219018 @default.
• W2897364747 hasRelatedWork W3141511544 @default.
• W2897364747 hasRelatedWork W3154045592 @default.
• W2897364747 hasRelatedWork W3178948399 @default.
• W2897364747 hasRelatedWork W367573814 @default.
• W2897364747 hasVolume "29" @default.
• W2897364747 isParatext "false" @default.
• W2897364747 isRetracted "false" @default.
• W2897364747 magId "2897364747" @default.
• W2897364747 workType "article" @default.